Cryoport, Inc. provides cryogenic logistics solutions to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures. It also provides Cryoport Express Standard Shippers, which are re-usable dry vapor liquid nitrogen storage containers for holding the biological material in the inner chamber; Cryoport Express High Volume Shippers, which use a dry vapor liquid nitrogen technology to maintain temperatures; and Cryoport Express CXVC1 Shipper can be used either as a dry vapor shipper or a liquid shipper. In addition, the company offers Cryoport Express CryoMax Shippers, a palletized dry shipper for lab moves and other high-volume transfers; Cryoport Express C3 Shippers designed to maintain a controlled temperature; Cryoport Express SmartPak II Condition Monitoring System to track the key aspects of each shipment; and Cryoport Express Analytics to track the time-based metrics for order processing time and on-time deliveries, as well as profiling shipping lanes to determine average transit times and predicting shipping exceptions based on historical metric. Further, it provides biological material holders that provide leak proof microbial barrier. Cryoport, Inc. was founded in 1999 and is headquartered in Irvine, California.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Freight transportation arrangement
Sub-IndustryN/A
SectorTransportation
Current SymbolNASDAQ:CYRX
Previous Symbol
CUSIPN/A
Phone949-470-2300
Debt
Debt-to-Equity RatioN/A
Current Ratio10.05
Quick Ratio10.00
Price-To-Earnings
Trailing P/E Ratio-29.41
Forward P/E Ratio-30.30
P/E GrowthN/A
Sales & Book Value
Annual Sales$11.95 million
Price / Sales24.47
Cash FlowN/A
Price / Cash FlowN/A
Book Value$0.70 per share
Price / Book14.29
Profitability
EPS (Most Recent Fiscal Year)($0.34)
Net Income$-7,890,000.00
Net Margins-55.44%
Return on Equity-40.81%
Return on Assets-36.43%
Miscellaneous
Employees57
Outstanding Shares29,240,000
Market Cap$289.77 million
OptionableOptionable
CryoPort (NASDAQ:CYRX) Frequently Asked Questions
What is CryoPort's stock symbol?
CryoPort trades on the NASDAQ under the ticker symbol "CYRX."
How were CryoPort's earnings last quarter?
CryoPort Inc (NASDAQ:CYRX) issued its quarterly earnings results on Thursday, November, 8th. The consumer goods maker reported ($0.07) earnings per share for the quarter, beating analysts' consensus estimates of ($0.08) by $0.01. The consumer goods maker earned $5.30 million during the quarter, compared to the consensus estimate of $5.06 million. CryoPort had a negative net margin of 55.44% and a negative return on equity of 40.81%. The business's revenue was up 76.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.08 EPS. View CryoPort's Earnings History.
When is CryoPort's next earnings date?
What price target have analysts set for CYRX?
4 equities research analysts have issued twelve-month target prices for CryoPort's stock. Their predictions range from $16.00 to $22.00. On average, they anticipate CryoPort's stock price to reach $19.75 in the next twelve months. This suggests a possible upside of 97.5% from the stock's current price. View Analyst Price Targets for CryoPort.
What is the consensus analysts' recommendation for CryoPort?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CryoPort in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CryoPort.
Has CryoPort been receiving favorable news coverage?
Headlines about CYRX stock have been trending somewhat positive this week, according to InfoTrie Sentiment. The research firm identifies positive and negative media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. CryoPort earned a news impact score of 1.7 on InfoTrie's scale. They also gave news coverage about the consumer goods maker a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future.
Who are some of CryoPort's key competitors?
Who are CryoPort's key executives?
CryoPort's management team includes the folowing people:
- Mr. Jerrell W. Shelton, Chairman, Pres & CEO (Age 73)
- Mr. Robert S. Stefanovich, CFO, Treasurer & Corp. Sec. (Age 53)
- Mr. Bret Bollinger, Chief Technology Officer (Age 51)
- Mr. Thomas J. Heinzen, VP of Corp. Devel. & Investor Relations
- Dr. Mark W. Sawicki Ph.D., Chief Commercial Officer
Who are CryoPort's major shareholders?
CryoPort's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.05%), Vanguard Group Inc (4.33%), Vanguard Group Inc. (4.33%), Creative Planning (2.05%), Allianz Asset Management GmbH (1.69%) and Taylor Wealth Management Partners (1.06%). Company insiders that own CryoPort stock include Jerrell Shelton and Richard J Berman. View Institutional Ownership Trends for CryoPort.
Which major investors are selling CryoPort stock?
CYRX stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, D.A. Davidson & CO., EAM Investors LLC, Royce & Associates LP, Vanguard Group Inc., Vanguard Group Inc, EAM Global Investors LLC and Taylor Frigon Capital Management LLC. Company insiders that have sold CryoPort company stock in the last year include Jerrell Shelton and Richard J Berman. View Insider Buying and Selling for CryoPort.
Which major investors are buying CryoPort stock?
CYRX stock was bought by a variety of institutional investors in the last quarter, including CQS Cayman LP, Victory Capital Management Inc., Allianz Asset Management GmbH, Wells Fargo & Company MN, Penn Capital Management Co. Inc., JPMorgan Chase & Co., JPMorgan Chase & Co. and Russell Investments Group Ltd.. View Insider Buying and Selling for CryoPort.
How do I buy shares of CryoPort?
Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CryoPort's stock price today?
One share of CYRX stock can currently be purchased for approximately $10.00.
How big of a company is CryoPort?
CryoPort has a market capitalization of $289.77 million and generates $11.95 million in revenue each year. The consumer goods maker earns $-7,890,000.00 in net income (profit) each year or ($0.34) on an earnings per share basis. CryoPort employs 57 workers across the globe.
What is CryoPort's official website?
How can I contact CryoPort?
CryoPort's mailing address is 17305 DAIMLER STREET, IRVINE CA, 92614. The consumer goods maker can be reached via phone at 949-470-2300 or via email at [email protected]
MarketBeat Community Rating for CryoPort (NASDAQ CYRX)
MarketBeat's community ratings are surveys of what our community members think about CryoPort and other stocks. Vote "Outperform" if you believe CYRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CYRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
